Target intelligence / Profile preview

Novel transcript, antisense to CCR6

Molecular classification
lncRNA, long non-coding RNA
01

Overview

ENSG00000308245, designated as "novel transcript, antisense to CCR6", encodes a long non-coding RNA (lncRNA), not a protein. This RNA gene is classified as an antisense transcript relative to the *CCR6* gene but does not encode a known therapeutic target such as a receptor, enzyme, transporter, or similar protein. There are no reported biological functions, disease associations, interacting drugs, or known biomarker or safety data for this transcript[3]. It is not considered a canonical therapeutic target nor a protein-coding gene suitable for classical drug targeting. Further context: - The main functional and disease-related information available in the literature and databases refers to its sense counterpart, *CCR6* (C-C motif chemokine receptor 6)[1][2][7]. - The field of lncRNAs is rapidly evolving, but as of now, ENSG00000308245 lacks sufficient functional characterization. In summary, ENSG00000308245 ("novel transcript, antisense to CCR6") is a non-coding RNA gene and *not* a canonical therapeutic/protein target[3].

Other names
ENSG00000308245

Beyond the preview

Go deeper on Novel transcript, antisense to CCR6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CCR6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call